Three products of the anticonvulsant are on back order from Acella Pharmaceuticals, and there is no expected resupply date. Mylan and Amneal Pharmaceuticals told ASHP their supply of gabapentin 250 milligram/5 milliliter oral solutions is available.
In its post, the ASHP clarified “gabapentin capsules are not affected by this shortage.”
As of May 2, the FDA has not reported a shortage of gabapentin.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
